243 related articles for article (PubMed ID: 32667139)
21. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.
Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M
Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033
[No Abstract] [Full Text] [Related]
22. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
Lourenco GF; Janitz M; Huang Y; Halliday GM
Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
[TBL] [Abstract][Full Text] [Related]
23. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis.
Broustal O; Camuzat A; Guillot-Noël L; Guy N; Millecamps S; Deffond D; Lacomblez L; Golfier V; Hannequin D; Salachas F; Camu W; Didic M; Dubois B; Meininger V; Le Ber I; Brice A;
J Alzheimers Dis; 2010; 22(3):765-9. PubMed ID: 21158017
[TBL] [Abstract][Full Text] [Related]
24. Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain.
Aoki N; Higashi S; Kawakami I; Kobayashi Z; Hosokawa M; Katsuse O; Togo T; Hirayasu Y; Akiyama H
Acta Neuropathol; 2012 Sep; 124(3):383-94. PubMed ID: 22526020
[TBL] [Abstract][Full Text] [Related]
25. Atypical FTLD-FUS associated with ALS-TDP: a case report.
Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
[TBL] [Abstract][Full Text] [Related]
26. Molecular basis of amyotrophic lateral sclerosis.
Liscic RM; Breljak D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import.
Darovic S; Prpar Mihevc S; Župunski V; Gunčar G; Štalekar M; Lee YB; Shaw CE; Rogelj B
J Cell Sci; 2015 Nov; 128(22):4151-9. PubMed ID: 26403203
[TBL] [Abstract][Full Text] [Related]
28. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.
Snowden JS; Hu Q; Rollinson S; Halliwell N; Robinson A; Davidson YS; Momeni P; Baborie A; Griffiths TD; Jaros E; Perry RH; Richardson A; Pickering-Brown SM; Neary D; Mann DM
Acta Neuropathol; 2011 Jul; 122(1):99-110. PubMed ID: 21424531
[TBL] [Abstract][Full Text] [Related]
29. Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUS.
Vazquez-Sanchez S; Tilkin B; Gasset-Rosa F; Zhang S; Piol D; McAlonis-Downes M; Artates J; Govea-Perez N; Verresen Y; Guo L; Cleveland DW; Shorter J; Da Cruz S
Mol Neurodegener; 2024 Jun; 19(1):46. PubMed ID: 38862967
[TBL] [Abstract][Full Text] [Related]
30. FUS pathology in basophilic inclusion body disease.
Munoz DG; Neumann M; Kusaka H; Yokota O; Ishihara K; Terada S; Kuroda S; Mackenzie IR
Acta Neuropathol; 2009 Nov; 118(5):617-27. PubMed ID: 19830439
[TBL] [Abstract][Full Text] [Related]
31. Abl kinase-mediated FUS Tyr526 phosphorylation alters nucleocytoplasmic FUS localization in FTLD-FUS.
Motaln H; Čerček U; Yamoah A; Tripathi P; Aronica E; Goswami A; Rogelj B
Brain; 2023 Oct; 146(10):4088-4104. PubMed ID: 37071594
[TBL] [Abstract][Full Text] [Related]
32. TDP-43 and FUS: a nuclear affair.
Dormann D; Haass C
Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347
[TBL] [Abstract][Full Text] [Related]
33. Brain region-specific synaptic function of FUS underlies the FTLD-linked behavioural disinhibition.
Wang JY; Ma GM; Tang XQ; Shi QL; Yu MC; Lou MM; He KW; Wang WY
Brain; 2023 May; 146(5):2107-2119. PubMed ID: 36345573
[TBL] [Abstract][Full Text] [Related]
34. Activity-dependent FUS dysregulation disrupts synaptic homeostasis.
Sephton CF; Tang AA; Kulkarni A; West J; Brooks M; Stubblefield JJ; Liu Y; Zhang MQ; Green CB; Huber KM; Huang EJ; Herz J; Yu G
Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4769-78. PubMed ID: 25324524
[TBL] [Abstract][Full Text] [Related]
35. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
A Armstrong R
Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
[TBL] [Abstract][Full Text] [Related]
36. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.
Seelaar H; Klijnsma KY; de Koning I; van der Lugt A; Chiu WZ; Azmani A; Rozemuller AJ; van Swieten JC
J Neurol; 2010 May; 257(5):747-53. PubMed ID: 19946779
[TBL] [Abstract][Full Text] [Related]
37. FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD.
Orozco D; Edbauer D
J Mol Med (Berl); 2013 Dec; 91(12):1343-54. PubMed ID: 23974990
[TBL] [Abstract][Full Text] [Related]
38. Als and Ftd: Insights into the disease mechanisms and therapeutic targets.
Liscic RM
Eur J Pharmacol; 2017 Dec; 817():2-6. PubMed ID: 29031901
[TBL] [Abstract][Full Text] [Related]
39. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.
Dutta K; Patel P; Rahimian R; Phaneuf D; Julien JP
Neurotherapeutics; 2017 Apr; 14(2):447-462. PubMed ID: 27928708
[TBL] [Abstract][Full Text] [Related]
40. [Conjoint pathological cascades mediated by RNA-binding proteins, TDP-43, FUS and ataxin-2].
Ito D
Rinsho Shinkeigaku; 2012; 52(11):1221-3. PubMed ID: 23196570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]